Your article was successfully shared with the contacts you provided.
SCARY THOUGHTS - It’s Halloween, so let’s talk about a nightmare that’s currently haunting defense lawyers and in-house counsel: an increase in privacy class actions. In the current environment of changing privacy laws and an uptick in litigation in the area, the defense bar is warning companies that it’s time to take a hard look at compliance before things get even more out of hand. “Compliance programs out there right now are finding the dirt underneath is turning to quicksand,” Sean M. Buckley, a member with Dykema Gossett in Dallas, told Law.com’s Colleen Murphy. “They are not keeping up with the velocity of the new laws and new regulations and new interpretations being passed as it relates to privacy and digital tracking.”
TALENT WRANGLERS - Multiple firms this quarter have announced new leaders or created new roles to oversee hiring and talent. As Law.com’s Andrew Maloney reports, law firms are always thinking about how they attract and retain talent. But it’s likely that several trends, like generational churn and many new lawyers’ “get-in, get-out” approach to Big Law, are top-of-mind for talent leaders across the industry. “Right now, it wouldn’t surprise me if some of the firms that have made these recent moves are trying to get in front of some of the likely talent issues they’ll be facing over the next five to 10 years, as they see a wave of baby boomers retire out of the firm, and younger attorneys increasingly see their time at a law firm as a short-term stay,” said Kristin Stark, a principal at Fairfax Associates.
ON THE RADAR - Robert J. Herrington of Greenberg Traurig and Robyn E. Bladow of Kirkland & Ellis have stepped in as defense counsel to Rite Aid and GlaxoSmithKline in a pending consumer class action regarding the defendants’ over-the-counter decongestant products containing phenylephrine. The case, filed Sept. 9 in California Eastern District Court by Singleton Schreiber LLP, is part of a string of lawsuits following an FDA advisory announcement that phenylephrine lacks efficacy for treating nasal congestion. The court action also takes aim at Johnson & Johnson, Procter & Gamble, Walgreens and others. The case, assigned to U.S. District Judge Troy L. Nunley, is 2:23-cv-01965, Pack et al v. Johnson & Johnson Consumer Companies, Inc. et al.Stay up on the latest state and federal litigation, as well as the latest corporate deals, with Law.com Radar.
EDITOR’S PICKS
Want to continue reading? Become an ALM Digital Reader for Free!
Benefits of a Digital Membership
Free access to 1 article* every 30 days
Access to the entire ALM network of websites
Unlimited access to the ALM suite of newsletters
Build custom alerts on any search topic of your choosing
With this subscription you will receive unlimited access to high quality, online, on-demand premium content from well-respected faculty in the legal industry. This is perfect for attorneys licensed in multiple jurisdictions or for attorneys that have fulfilled their CLE requirement but need to access resourceful information for their practice areas. View Now
Our Team Account subscription service is for legal teams of four or more attorneys. Each attorney is granted unlimited access to high quality, on-demand premium content from well-respected faculty in the legal industry along with administrative access to easily manage CLE for the entire team. View Now
Gain access to some of the most knowledgeable and experienced attorneys with our 2 bundle options! Our Compliance bundles are curated by CLE Counselors and include current legal topics and challenges within the industry. Our second option allows you to build your bundle and strategically select the content that pertains to your needs. Both options are priced the same. View Now
Law.com Compass includes access to our exclusive industry reports, combining the unmatched expertise of our analyst team with ALM’s deep bench of proprietary information to provide insights that can’t be found anywhere else.
Law.com Compass delivers you the full scope of information, from the rankings of the Am Law 200 and NLJ 500 to intricate details and comparisons of firms’ financials, staffing, clients, news and events.
